Thelansis

 Chronic lymphocytic leukemia (CLL) is characterised by clonal proliferation and accumulation of mature, typically CD5-positive B cells in the blood, bone marrow, lymph nodes, and spleen. The ability to generate clonal B cells may be acquired at the hematopoietic stem cell (HSC) stage, implying that the primary leukemogenic event in CLL may be multipotent, self-renewing HSCs. CLL cell survival depends entirely on a permissive microenvironment composed of cellular components such as macrophages, T cells, or stromal follicular dendritic cells that provide stimuli for the activation of critical survival and pro-proliferative signaling pathways in transformed cells. To support CLL cells survival, this microenvironment produces a variety of essential proteins (chemokines, cytokines, and angiogenic factors) that interact with leukemic cells via appropriate surface receptors or adhesion molecules. In the USA, more than 16.850 cases of CLL were diagnosed in the year 2020, and appr...